weight loss drug - Search News

Weight Loss Drug Demand Drives Eli Lilly Sales

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular diabetes and weight-loss treatments in new markets.

CNBC on MSN · 17h

Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company's quarterly earnings topped Wall Street estimates,

USA TODAY on MSN · 3d

Here's why researchers think most people stop taking weight loss drugs within a year

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

Nature1d

The weight-loss drugs being tested in 2025: will they beat Ozempic?

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

21m

The Big Question: should weight-loss injections face tougher restrictions?

Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those ...

14h

Whoopi Goldberg Slams Weight Loss Drug Ad for Using AI Version of Her Face: ‘Do Not Indulge This’

Whoopi Goldberg wants fans to know that the ad circulating on Instagram appearing to show her endorsing a weight loss drug is ...

1don MSN

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Weight Loss Drug Demand Drives Eli Lilly Sales

Related topics